Floatz logo

17-beta-estradiol

Female Breast Cancer

University of Wisconsin, MadisonPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Female Breast Cancer cohort.

Asset / SponsorPhaseRating
Arimidex
Ahon Pharmaceutical Co., Ltd.
Phase 4BBB
PROPOFOL
Tata Memorial Centre
Phase 4BB
Sevoflurane
Tata Memorial Centre
Phase 4BB
Zoladex
Ahon Pharmaceutical Co., Ltd.
Phase 3BB
Gtx-006
Peking Union Medical College Hospital
Phase 4BB

View all 14 →

Same molecule, other indications

17-beta-estradiol is also rated in:

Turner SyndromeDormant
BBB
Indicative ·
76 / 100
View asset →
Infertility, FemaleDormant
BBB
Indicative ·
75 / 100
View asset →
HypogonadismDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →